Persistent Asset Partners Ltd
- SEC CIK
- 0002056052
- Latest filing
- Aug 6, 2026
MNPR holding history
Monopar Therapeutics in every 13F filed by Persistent Asset Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MNPR overviewAll 13F holders of MNPRFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,271
- Value
- $117.7K
- % of portfolio
- <0.1%
- Quarters held
- 2
- Since Q1 2026